findmyKOL
Clinical trialNCT02741687CompletedPhase 4Interventional

Sitagliptin in Non-Diabetic Patients Undergoing General Surgery

SponsorEmory UniversityEnrollment80Hyperglycemia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to compare sitagliptin with a placebo for the prevention of high glucose after general surgery.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Emory University Hospital Midtown

    Atlanta, Georgia, United States

  • Grady Memorial Hospital

    Atlanta, Georgia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Long acting basal insulinPlaceboSitagliptin →Supplemental insulin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2016
Primary completion
30 Apr 2017
Completion
30 Apr 2017
Last update posted
27 Jun 2018
Registered enrollment
80
Registry id
NCT02741687
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.